Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 2025

Cognitive performance and blood biomarkers: Insights into their relationship and predicting high Amyloid Probability Score in cognitively impaired older adults.

View Full Paper
Ask AI
Bookmark
Share

Authors

QCQi ChuKMKohei MorimotoHKHisatomo Kowa

Discussion

Loading...

Member takes

Overview

Observational analysis reveals associations between cognitive performance, blood biomarkers, indicating potential diagnostic paths for Alzheimer's disease.

Key Points

  • Cognitive performance is associated with blood biomarkers, suggesting a link to Alzheimer's disease.
  • 47% of the participants demonstrated lower MMSE scores in the Cogstate Brief Battery assessments.
  • Spearman correlation analysis shows significant relationships between MMSE and cognitive tasks in older adults.
  • The developed predictive model for high Amyloid Probability Score achieved an accuracy of 80.8% in cognitively impaired individuals.

Cite This Study

Chu et al. (2025) studied this question.

synapsesocial.com/papers/68c6df6de03a6c7bdc170fachttps://doi.org/10.1177/13872877251372958
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment2023 · 34 citations
  2. 2Plasma amyloid-β biomarkers for predicting amyloid positivity in mild cognitive impairment: a prospective cohort study2024
  3. 3Blood biomarkers to improve dementia diagnostic accuracy: a cross-sectional analysis.2026
  4. 4Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment2025 · 1 citations
  5. 5Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals2025